Filing Flows › Comparisons › FHTX vs RIGL
Foghorn Therapeutics vs Rigel Pharmaceuticals: FHTX and RIGL compared
Foghorn Therapeutics is the larger company: $83.5M of revenue in its latest quarter (Q3 2026) against $80.9M for Rigel Pharmaceuticals (Q3 2026). Foghorn Therapeutics is growing faster (+925% against +16% a year earlier). Foghorn Therapeutics is more profitable, with an operating margin of 67.8% against 21.1%.
Where the money goes: FHTX and RIGL
Foghorn Therapeutics (FHTX) · Q3 2026
Foghorn Therapeutics, Q3 2026: revenue $83.5M (+925% year over year), operating margin 67.8%, net earnings $58.1M, operating cash flow −$18.2M. The chart follows the revenue to costs, profit and cash.
Rigel Pharmaceuticals (RIGL) · Q3 2026
Rigel Pharmaceuticals, Q3 2026: revenue $80.9M (+16% year over year), operating margin 21.1%, net earnings $13.2M, operating cash flow $34.6M. The chart follows the revenue to costs, profit and cash.
| Foghorn Therapeutics (FHTX) | Rigel Pharmaceuticals (RIGL) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $83.5M | $80.9M |
| Revenue growth, Y/Y | +925% | +16% |
| Operating margin | 67.8% | 21.1% |
| Net earnings | $58.1M | $13.2M |
| Net margin | 69.6% | 16.3% |
| Operating cash flow | −$18.2M | $34.6M |
| Market value | $132M | — |
| Analysts’ mean target | $4.17 | — |
Where the revenue comes from
Rigel Pharmaceuticals
- Product sales, net: $72.3M (89%)
- Contract revenues from collaborations and other: $8.6M (11%)
Questions
Which is bigger, Foghorn Therapeutics or Rigel Pharmaceuticals?
Foghorn Therapeutics is the larger company: $83.5M of revenue in its latest quarter (Q3 2026) against $80.9M for Rigel Pharmaceuticals (Q3 2026).
Is Foghorn Therapeutics or Rigel Pharmaceuticals growing faster?
Foghorn Therapeutics is growing faster (+925% against +16% a year earlier).
Which is more profitable, Foghorn Therapeutics or Rigel Pharmaceuticals?
Foghorn Therapeutics is more profitable, with an operating margin of 67.8% against 21.1%.
More: Foghorn Therapeutics earnings · how Foghorn Therapeutics makes money · Rigel Pharmaceuticals earnings · how Rigel Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 9, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.